Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes.

The global market for Kidney Cancer Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnostics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Kidney Cancer Diagnostics by region & country, by Type, and by Application.

The Kidney Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnostics.

Market Segmentation

Scope of Kidney Cancer Diagnostics - Market Report

Report Metric	Details
Report Name	Kidney Cancer Diagnostics - Market
CAGR	5%
Segment by Type:	Immunohistochemistry Urine Analysis Blood Chemistry Test Others
Segment by Application	Hospitals Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Kidney Cancer Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Kidney Cancer Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Kidney Cancer Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Kidney Cancer Diagnostics - Market report?

Ans: The main players in the Kidney Cancer Diagnostics - Market are Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics

What are the Application segmentation covered in the Kidney Cancer Diagnostics - Market report?

Ans: The Applications covered in the Kidney Cancer Diagnostics - Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Kidney Cancer Diagnostics - Market report?

Ans: The Types covered in the Kidney Cancer Diagnostics - Market report are Immunohistochemistry, Urine Analysis, Blood Chemistry Test, Others

1 Market Overview

1.1 Kidney Cancer Diagnostics Product Introduction

1.2 Global Kidney Cancer Diagnostics Market Size Forecast

1.2.1 Global Kidney Cancer Diagnostics Sales Value (2019-2030)

1.2.2 Global Kidney Cancer Diagnostics Sales Volume (2019-2030)

1.2.3 Global Kidney Cancer Diagnostics Sales Price (2019-2030)

1.3 Kidney Cancer Diagnostics Market Trends & Drivers

1.3.1 Kidney Cancer Diagnostics Industry Trends

1.3.2 Kidney Cancer Diagnostics Market Drivers & Opportunity

1.3.3 Kidney Cancer Diagnostics Market Challenges

1.3.4 Kidney Cancer Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Kidney Cancer Diagnostics Players Revenue Ranking (2023)

2.2 Global Kidney Cancer Diagnostics Revenue by Company (2019-2024)

2.3 Global Kidney Cancer Diagnostics Players Sales Volume Ranking (2023)

2.4 Global Kidney Cancer Diagnostics Sales Volume by Company Players (2019-2024)

2.5 Global Kidney Cancer Diagnostics Average Price by Company (2019-2024)

2.6 Key Manufacturers Kidney Cancer Diagnostics Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Kidney Cancer Diagnostics Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Kidney Cancer Diagnostics

2.9 Kidney Cancer Diagnostics Market Competitive Analysis

2.9.1 Kidney Cancer Diagnostics Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Kidney Cancer Diagnostics Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnostics as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immunohistochemistry

3.1.2 Urine Analysis

3.1.3 Blood Chemistry Test

3.1.4 Others

3.2 Global Kidney Cancer Diagnostics Sales Value by Type

3.2.1 Global Kidney Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Kidney Cancer Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Kidney Cancer Diagnostics Sales Value, by Type (%) (2019-2030)

3.3 Global Kidney Cancer Diagnostics Sales Volume by Type

3.3.1 Global Kidney Cancer Diagnostics Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Kidney Cancer Diagnostics Sales Volume, by Type (2019-2030)

3.3.3 Global Kidney Cancer Diagnostics Sales Volume, by Type (%) (2019-2030)

3.4 Global Kidney Cancer Diagnostics Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Specialty Clinics

4.1.3 Others

4.2 Global Kidney Cancer Diagnostics Sales Value by Application

4.2.1 Global Kidney Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Kidney Cancer Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Kidney Cancer Diagnostics Sales Value, by Application (%) (2019-2030)

4.3 Global Kidney Cancer Diagnostics Sales Volume by Application

4.3.1 Global Kidney Cancer Diagnostics Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Kidney Cancer Diagnostics Sales Volume, by Application (2019-2030)

4.3.3 Global Kidney Cancer Diagnostics Sales Volume, by Application (%) (2019-2030)

4.4 Global Kidney Cancer Diagnostics Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Kidney Cancer Diagnostics Sales Value by Region

5.1.1 Global Kidney Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Kidney Cancer Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Kidney Cancer Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Kidney Cancer Diagnostics Sales Value by Region (%), (2019-2030)

5.2 Global Kidney Cancer Diagnostics Sales Volume by Region

5.2.1 Global Kidney Cancer Diagnostics Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Kidney Cancer Diagnostics Sales Volume by Region (2019-2024)

5.2.3 Global Kidney Cancer Diagnostics Sales Volume by Region (2025-2030)

5.2.4 Global Kidney Cancer Diagnostics Sales Volume by Region (%), (2019-2030)

5.3 Global Kidney Cancer Diagnostics Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Kidney Cancer Diagnostics Sales Value, 2019-2030

5.4.2 North America Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Kidney Cancer Diagnostics Sales Value, 2019-2030

5.5.2 Europe Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Kidney Cancer Diagnostics Sales Value, 2019-2030

5.6.2 Asia Pacific Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Kidney Cancer Diagnostics Sales Value, 2019-2030

5.7.2 South America Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Kidney Cancer Diagnostics Sales Value, 2019-2030

5.8.2 Middle East & Africa Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Kidney Cancer Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Kidney Cancer Diagnostics Sales Value

6.2.1 Key Countries/Regions Kidney Cancer Diagnostics Sales Value, 2019-2030

6.2.2 Key Countries/Regions Kidney Cancer Diagnostics Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Kidney Cancer Diagnostics Sales Value, 2019-2030

6.3.2 United States Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Kidney Cancer Diagnostics Sales Value, 2019-2030

6.4.2 Europe Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Kidney Cancer Diagnostics Sales Value, 2019-2030

6.5.2 China Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Kidney Cancer Diagnostics Sales Value, 2019-2030

6.6.2 Japan Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Kidney Cancer Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Kidney Cancer Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Kidney Cancer Diagnostics Sales Value, 2019-2030

6.9.2 India Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Kidney Cancer Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Company Information

7.1.2 Thermo Fisher Scientific Introduction and Business Overview

7.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Product Offerings

7.1.5 Thermo Fisher Scientific Recent Development

7.2 Abbott Laboratories

7.2.1 Abbott Laboratories Company Information

7.2.2 Abbott Laboratories Introduction and Business Overview

7.2.3 Abbott Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Abbott Laboratories Kidney Cancer Diagnostics Product Offerings

7.2.5 Abbott Laboratories Recent Development

7.3 Illumina

7.3.1 Illumina Company Information

7.3.2 Illumina Introduction and Business Overview

7.3.3 Illumina Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Illumina Kidney Cancer Diagnostics Product Offerings

7.3.5 Illumina Recent Development

7.4 Quest Diagnostics Incorporated

7.4.1 Quest Diagnostics Incorporated Company Information

7.4.2 Quest Diagnostics Incorporated Introduction and Business Overview

7.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product Offerings

7.4.5 Quest Diagnostics Incorporated Recent Development

7.5 Roche Holding

7.5.1 Roche Holding Company Information

7.5.2 Roche Holding Introduction and Business Overview

7.5.3 Roche Holding Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Roche Holding Kidney Cancer Diagnostics Product Offerings

7.5.5 Roche Holding Recent Development

7.6 Myriad Genetics

7.6.1 Myriad Genetics Company Information

7.6.2 Myriad Genetics Introduction and Business Overview

7.6.3 Myriad Genetics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Myriad Genetics Kidney Cancer Diagnostics Product Offerings

7.6.5 Myriad Genetics Recent Development

7.7 NeoGenomics Laboratories

7.7.1 NeoGenomics Laboratories Company Information

7.7.2 NeoGenomics Laboratories Introduction and Business Overview

7.7.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.7.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Product Offerings

7.7.5 NeoGenomics Laboratories Recent Development

7.8 NanoString Technologies

7.8.1 NanoString Technologies Company Information

7.8.2 NanoString Technologies Introduction and Business Overview

7.8.3 NanoString Technologies Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.8.4 NanoString Technologies Kidney Cancer Diagnostics Product Offerings

7.8.5 NanoString Technologies Recent Development

7.9 Sysmex Corporation

7.9.1 Sysmex Corporation Company Information

7.9.2 Sysmex Corporation Introduction and Business Overview

7.9.3 Sysmex Corporation Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Sysmex Corporation Kidney Cancer Diagnostics Product Offerings

7.9.5 Sysmex Corporation Recent Development

7.10 Rosetta Genomics

7.10.1 Rosetta Genomics Company Information

7.10.2 Rosetta Genomics Introduction and Business Overview

7.10.3 Rosetta Genomics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Rosetta Genomics Kidney Cancer Diagnostics Product Offerings

7.10.5 Rosetta Genomics Recent Development

8 Industry Chain Analysis

8.1 Kidney Cancer Diagnostics Industrial Chain

8.2 Kidney Cancer Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Kidney Cancer Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Kidney Cancer Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Abbott Laboratories

Illumina Inc

Quest Diagnostics Incorporated

Roche Holding

Myriad Genetics

Neogenomics Laboratories

Nanostring Technologies

Sysmex Corporation

Rosetta Genomics

List of Tables

Table 1. Kidney Cancer Diagnostics Market Trends

Table 2. Kidney Cancer Diagnostics Market Drivers & Opportunity

Table 3. Kidney Cancer Diagnostics Market Challenges

Table 4. Kidney Cancer Diagnostics Market Restraints

Table 5. Global Kidney Cancer Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Kidney Cancer Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Global Kidney Cancer Diagnostics Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Kidney Cancer Diagnostics Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Kidney Cancer Diagnostics Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Kidney Cancer Diagnostics Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Kidney Cancer Diagnostics Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Kidney Cancer Diagnostics

Table 13. Global Kidney Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnostics as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Kidney Cancer Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Kidney Cancer Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Kidney Cancer Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Kidney Cancer Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Kidney Cancer Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Kidney Cancer Diagnostics Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Kidney Cancer Diagnostics Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Kidney Cancer Diagnostics Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Kidney Cancer Diagnostics Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Kidney Cancer Diagnostics Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Kidney Cancer Diagnostics Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Kidney Cancer Diagnostics Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Kidney Cancer Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Kidney Cancer Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Kidney Cancer Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Kidney Cancer Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Kidney Cancer Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Kidney Cancer Diagnostics Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Kidney Cancer Diagnostics Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Kidney Cancer Diagnostics Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Kidney Cancer Diagnostics Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Kidney Cancer Diagnostics Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Kidney Cancer Diagnostics Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Kidney Cancer Diagnostics Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Kidney Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Kidney Cancer Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Kidney Cancer Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Kidney Cancer Diagnostics Sales Value by Region (2019-2024) & (%)

Table 44. Global Kidney Cancer Diagnostics Sales Value by Region (2025-2030) & (%)

Table 45. Global Kidney Cancer Diagnostics Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Kidney Cancer Diagnostics Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Kidney Cancer Diagnostics Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Kidney Cancer Diagnostics Sales Volume by Region (2019-2024) & (%)

Table 49. Global Kidney Cancer Diagnostics Sales Volume by Region (2025-2030) & (%)

Table 50. Global Kidney Cancer Diagnostics Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Kidney Cancer Diagnostics Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Kidney Cancer Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Kidney Cancer Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Kidney Cancer Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Kidney Cancer Diagnostics Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Kidney Cancer Diagnostics Sales Volume, (2025-2030) & (K Units)

Table 57. Thermo Fisher Scientific Company Information

Table 58. Thermo Fisher Scientific Introduction and Business Overview

Table 59. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Thermo Fisher Scientific Kidney Cancer Diagnostics Product Offerings

Table 61. Thermo Fisher Scientific Recent Development

Table 62. Abbott Laboratories Company Information

Table 63. Abbott Laboratories Introduction and Business Overview

Table 64. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Abbott Laboratories Kidney Cancer Diagnostics Product Offerings

Table 66. Abbott Laboratories Recent Development

Table 67. Illumina Company Information

Table 68. Illumina Introduction and Business Overview

Table 69. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Illumina Kidney Cancer Diagnostics Product Offerings

Table 71. Illumina Recent Development

Table 72. Quest Diagnostics Incorporated Company Information

Table 73. Quest Diagnostics Incorporated Introduction and Business Overview

Table 74. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product Offerings

Table 76. Quest Diagnostics Incorporated Recent Development

Table 77. Roche Holding Company Information

Table 78. Roche Holding Introduction and Business Overview

Table 79. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Roche Holding Kidney Cancer Diagnostics Product Offerings

Table 81. Roche Holding Recent Development

Table 82. Myriad Genetics Company Information

Table 83. Myriad Genetics Introduction and Business Overview

Table 84. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Myriad Genetics Kidney Cancer Diagnostics Product Offerings

Table 86. Myriad Genetics Recent Development

Table 87. NeoGenomics Laboratories Company Information

Table 88. NeoGenomics Laboratories Introduction and Business Overview

Table 89. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. NeoGenomics Laboratories Kidney Cancer Diagnostics Product Offerings

Table 91. NeoGenomics Laboratories Recent Development

Table 92. NanoString Technologies Company Information

Table 93. NanoString Technologies Introduction and Business Overview

Table 94. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. NanoString Technologies Kidney Cancer Diagnostics Product Offerings

Table 96. NanoString Technologies Recent Development

Table 97. Sysmex Corporation Company Information

Table 98. Sysmex Corporation Introduction and Business Overview

Table 99. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Sysmex Corporation Kidney Cancer Diagnostics Product Offerings

Table 101. Sysmex Corporation Recent Development

Table 102. Rosetta Genomics Company Information

Table 103. Rosetta Genomics Introduction and Business Overview

Table 104. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Rosetta Genomics Kidney Cancer Diagnostics Product Offerings

Table 106. Rosetta Genomics Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Kidney Cancer Diagnostics Downstream Customers

Table 110. Kidney Cancer Diagnostics Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Kidney Cancer Diagnostics Product Picture

Figure 2. Global Kidney Cancer Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Kidney Cancer Diagnostics Sales Volume (2019-2030) & (K Units)

Figure 5. Global Kidney Cancer Diagnostics Sales Price (2019-2030) & (US$/Unit)

Figure 6. Kidney Cancer Diagnostics Report Years Considered

Figure 7. Global Kidney Cancer Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Kidney Cancer Diagnostics Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney Cancer Diagnostics Revenue in 2023

Figure 10. Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Immunohistochemistry Picture

Figure 12. Urine Analysis Picture

Figure 13. Blood Chemistry Test Picture

Figure 14. Others Picture

Figure 15. Global Kidney Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Kidney Cancer Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Kidney Cancer Diagnostics Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Kidney Cancer Diagnostics Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Kidney Cancer Diagnostics Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Hospitals

Figure 21. Product Picture of Specialty Clinics

Figure 22. Product Picture of Others

Figure 23. Global Kidney Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Kidney Cancer Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Kidney Cancer Diagnostics Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Kidney Cancer Diagnostics Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Kidney Cancer Diagnostics Price by Application (2019-2030) & (US$/Unit)

Figure 28. North America Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Kidney Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Kidney Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Kidney Cancer Diagnostics Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Kidney Cancer Diagnostics Sales Volume (%), (2019-2030)

Figure 40. United States Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 46. China Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 48. China Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 58. India Kidney Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Kidney Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 60. India Kidney Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 61. Kidney Cancer Diagnostics Industrial Chain

Figure 62. Kidney Cancer Diagnostics Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37I14671

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G18542

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A14903

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Kidney Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-10D8044

Kidney Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Kidney Cancer Diagnostics - Market Size

Kidney Cancer Diagnostics - Market

Report Scope

Scope of Kidney Cancer Diagnostics - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Kidney Cancer Diagnostics - Market report?

What are the Application segmentation covered in the Kidney Cancer Diagnostics - Market report?

What are the Type segmentation covered in the Kidney Cancer Diagnostics - Market report?

FEATURED COMPANIES

RELATED REPORTS